ProfileGDS4284 / 207271_x_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 3% 3% 16% 7% 3% 2% 3% 3% 3% 3% 2% 21% 3% 4% 6% 4% 10% 4% 3% 4% 6% 3% 7% 5% 14% 2% 6% 4% 2% 7% 3% 3% 5% 3% 2% 2% 4% 3% 2% 7% 5% 3% 3% 3% 3% 3% 4% 1% 6% 4% 3% 5% 4% 3% 9% 3% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control6.354923
GSM687648Patient 402 control6.377163
GSM687653Patient 403 control26.155116
GSM687658Patient 404 control12.69057
GSM687663Patient 411 control7.953653
GSM687668Patient 422 control5.972442
GSM687673Patient 424 control7.310923
GSM687678Patient 425 control8.330143
GSM687683Patient 427 control8.633783
GSM687688Patient 428 control6.332883
GSM687695Patient 441 control10.72812
GSM687699Patient 443 control53.409821
GSM687704Patient 444 control6.764433
GSM687707Patient 448 control11.36534
GSM687712Patient 449 control11.88726
GSM687719Patient 450 control10.97764
GSM687724Patient 451 control20.290510
GSM687728Patient 452 control9.711314
GSM687646Patient 401 treated 24h6.713863
GSM687649Patient 402 treated 24h6.951394
GSM687665Patient 411 treated 24h12.50916
GSM687651Patient 402 treated 4 weeks6.937393
GSM687667Patient 411 treated 4 weeks13.53587
GSM687670Patient 422 treated 24h11.1095
GSM687671Patient 422 treated 4 weeks22.148314
GSM687654Patient 403 treated 24h4.61592
GSM687675Patient 424 treated 24h12.56266
GSM687685Patient 427 treated 24h8.168764
GSM687656Patient 403 treated 4 weeks5.396742
GSM687677Patient 424 treated 4 weeks12.47347
GSM687687Patient 427 treated 4 weeks5.94823
GSM687692Patient 428 treated 4h7.319913
GSM687716Patient 449 treated 4h10.4885
GSM687722Patient 450 treated 4h9.140753
GSM687680Patient 425 treated 24h5.747972
GSM687690Patient 428 treated 24h4.84852
GSM687700Patient 443 treated 24h15.83114
GSM687705Patient 444 treated 24h7.645423
GSM687714Patient 449 treated 24h5.852172
GSM687721Patient 450 treated 24h16.09287
GSM687682Patient 425 treated 4 weeks9.217015
GSM687694Patient 428 treated 4 weeks6.237553
GSM687702Patient 443 treated 4 weeks8.707473
GSM687718Patient 449 treated 4 weeks7.427373
GSM687723Patient 450 treated 4 weeks7.367623
GSM687661Patient 404 treated 4h7.072693
GSM687710Patient 448 treated 4h8.424924
GSM687726Patient 451 treated 4h5.810391
GSM687730Patient 452 treated 4h33.33566
GSM687660Patient 404 treated 24h13.65494
GSM687697Patient 441 treated 24h12.50543
GSM687709Patient 448 treated 24h10.90025
GSM687725Patient 451 treated 24h12.46354
GSM687729Patient 452 treated 24h12.00723
GSM687727Patient 451 treated 4 weeks19.1929
GSM687731Patient 452 treated 4 weeks8.658643